OJ-Bio Ltd is a young and innovative joint venture company with expertise in measuring protein biomarkers on biochips based on the expertise of its parent companies. Through converging state of the art electronics of JRC and cutting edge nano-biotechnology of Orla, OJ-Bio developed Xtalline, a portable diagnostic testing device allowing quick and reliable test anywhere by anyone.
Xtalline enables multiple tests and applications in one device. OJ-Bio’s lead application is a biochip that can measure the biomarker C-Reactive Protein (CRP), which allows determination of whether an infection is caused by bacteria and whether or not antibiotics are required. Additionally, products for other applications including periodontal disease, flu and HIV are in the pipeline. OJ-Bio welcomes partnerships to find new and additional applications for its technology to develop new products and discover new commercial opportunities.
Published on 28 September in News Medical Advanced smartphone-enabled medical device technology for the rapid and cost-effective detection of infectious diseases will be featured at this year’s prestigious Medica show. The UK-based OJ-Bio Ltd (Stand Continue Reading
A North East medical device company has raised new financial backing as it continues to work towards the commercialisation of its breakthrough diagnostic technology. OJ Bio has secured further funding from Japanese electronics partner Japan Continue Reading
Laura White from Newcastle University interviewed Professor Jeremy Lakey, Dr Dale Athey and Dr Andrew Sails about the core technology and applications of OJ-Bio. The link to the video and written article can be found Continue Reading